• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Wearing surgical masks in public spaces reduces risks of respiratory symptoms

byAlex Chan
July 31, 2024
in Infectious Disease, Public Health, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Wearing surgical face masks was superior to not wearing surgical face masks in reducing the risk of respiratory symptoms over 14 days among Norwegian adults.

Evidence Rating Level: 2 (Good)

During the COVID-19 pandemic, wearing face masks was a widely implemented public health measure to limit the spread of the virus; however, its effectiveness in lowering the risk of respiratory infections is mixed. This pragmatic parallel two-arm individually randomized superiority trial thus evaluated the personal protective effect of wearing versus not wearing surgical face masks in public spaces over 14 days on self-reported symptoms consistent with a respiratory infection. This study was conducted in Norway between 10 February 2023 and 27 April 2023, after the most acute phase of the COVID-19 pandemic, but during the normal influenza season in the Nordic countries. 4647 adults > 18 years of age were randomised 1:1 to the intervention arm and control arm. Participants in the intervention arm were assigned to wear a surgical face mask in public spaces (eg, shopping centres, streets, public transport) over a 14-day period. Participants in the control arm were assigned to not wear a surgical face mask in public places. Among the participants randomized, 4575 participants were included in the intention-to-treat analysis, with 2313 (50.6%) in the intervention arm (mean age ±SD = 51 ±15.2) years, female N (%) =1423 (61.5%)) and 2262 (49.4%) in the control arm (mean age ±SD = 51 ±16.3 years, female N (%) = 1365 (60.3%)). Number of participants that self-reported respiratory symptoms consistent with respiratory infection were 163 (8.9%) in the intervention arm and 239 (12.2%) in the control arm. Compared to not wearing a mask, wearing a mask reduced the odds and absolute risk of self-reported symptoms (marginal odds ratio (OR) 0.71, 95% CI 0.58 to 0.87; P = 0.001; absolute risk difference −3.2%, 95% CI −5.2% to −1.3%; P < 0.001). No statistically significant effect was found on self-reported or registered COVID-19 infection. Overall, study results suggest that wearing face masks may be effective in reducing the incidence of self-reported respiratory symptoms consistent with respiratory tract infections.

Click to read the study in BMJ

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2 Minute Medicine Rewind June 9, 2025

Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension

Midlife weight loss is associated with decreased risk of mortality and chronic disease

Tags: infectious diseasespersonal protective equipmentpublic healthpulmonologyrespirologyurti
Previous Post

Early weight-bearing after ankle surgery may be as effective and more cost-efficient than delayed weight-bearing

Next Post

AstraZeneca’s Tagrisso and chemotherapy pairing have been approved in Canada for treatment in locally advanced or metastatic non-small cell lung cancer.

RelatedReports

Weekly Rewinds

2 Minute Medicine Rewind June 9, 2025

June 9, 2025
Multiple-electrode switching radiofrequency ablation may successfully treat lung tumors
Cardiology

Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension

June 5, 2025
Sleep duration inversely related to childhood type 2 diabetes risk makers
Chronic Disease

Midlife weight loss is associated with decreased risk of mortality and chronic disease

June 3, 2025
Chronic Disease

Incidence and prevalence of dementia among US Medicare beneficiaries between 2015 – 2021

May 31, 2025
Next Post
Many lung cancers visible on prior imaging studies

AstraZeneca's Tagrisso and chemotherapy pairing have been approved in Canada for treatment in locally advanced or metastatic non-small cell lung cancer.

#VisualAbstract: Risankizumab was Non-Inferior to Ustekinumab for the Clinical Remission of Moderate-to-Severe Crohn’s Disease

#VisualAbstract: Risankizumab was Non-Inferior to Ustekinumab for the Clinical Remission of Moderate-to-Severe Crohn's Disease

Subdural irrigation in burr-hole drainage procedure reduces reoperation rate in patients with chronic subdural hematoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients
  • Artificial intelligence may assist in early detection of decreased ejection fraction on echocardiograms
  • #VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.